Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 48 | Vintage Vibes

Buy-now-pay-later closure hits unfunded medicines

Businesses relying on the popular but contentious payments model are finding their operations increasingly difficult to stack up, reports Andrew Bevin.

Newsroom.co.nz

Catalyst Pharmaceuticals (CPRX): Is Now the Time to Buy This Pharma Stock?

Catalyst Pharmaceuticals (CPRX) reported robust second-quarter results, with its topline reaching an all-time high. Does that mean it's time to buy the pharma stock now? Let’s look at its financial metrics to gauge its prospects….

StockNews.com

Big Pharma’s playbook for expensive meds

Here are just a few of the many examples of drug pricing practices that have driven consumers to demand change

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

What is the abortion case in front of the US supreme court right now?

On Tuesday the justices heard oral arguments on a rightwing effort to roll back access to a key abortion pill

The Guardian - US

Walgreens Boots Alliance (WBA), CVS Health (CVS), and Rite Aid (RAD): Buy, Hold or Sell?

With rising healthcare spending, the drugstore industry is poised to witness solid growth amid heightened demand. As a result, leading industry players CVS Health (CVS), Walgreens Boots Alliance (WBA), and Rite Aid (RAD) stand to benefit. However, should you Buy, Hold, or Sell these stocks? Keep reading to find out.

StockNews.com

NDTV’s Jan Vishwas Act debate: Viewers should know if panelists have conflict of interest

Over the last decade, I have been advocating for revamping drug regulatory laws in India. I have encountered much opposition in the process – some from the pharmaceutical industry and a lot more from public health activists working on access to medicine, many of whom look at quality and price…

Newslaundry

Captagon: $3 narcotic pill sold in the Gulf worries European officials

Europe is bracing for the possible influx of a drug that’s hooked the Middle East as political shifts and crackdowns in the Gulf spur producers in Syria and Lebanon to tap new markets.

The Times of India

Read news from The Economist, FT, and more,
with one subscription

Which of These 3 Pharma Stocks Are a Buy?

The pharma industry is expected to experience substantial growth in the coming years with expanding global medical needs. So, which of these pharma stocks, Ipsen (IPSEY), Collegium Pharmaceutical (COLL), and SNDL (SNDL), are a buy now? Keep reading.

StockNews.com

Which of These 3 Medical Stocks Has the Better Growth Opportunities?

The medical sector is expected to grow amid steady demand and technological advancements. So, let's analyze which of these stocks, CVS Health (CVS), Walgreens Boots Alliance (WBA), and TRxADE HEALTH (MEDS), has the better growth opportunities.

StockNews.com

Supreme Court Halts Purdue Pharma’s $6B Settlement From A Challenge In A Lawsuit

The Supreme Court temporarily blocked a bankruptcy settlement by Purdue Pharma that would shield victims from civil lawsuits.

Zenger

Family of Henrietta Lacks files new lawsuit over cells harvested without her consent

The family of Henrietta Lacks has filed another lawsuit accusing a second company of unjustly profiting off her cells for generations

The Independent UK

Canopy Growth (CGC) vs. Collegium Pharmaceutical (COLL): Which Pharma Stock Is the Better Buy for Growth Investors?

The pharma industry is poised for long-term growth supported by increasing demand for drugs worldwide and technological advancements. While leading pharma stocks Collegium Pharmaceutical (COLL) and Canopy Growth (CGC) should benefit from the industry tailwinds, let us determine which is the better buy.

StockNews.com

Painkiller on Netflix review: this drama exploring America’s opioid crisis feels achingly real

This show skilfully captures the impossible emotional complexity of loving an addict

Evening Standard

An illicit, Chinese-owned lab fueled conspiracy theories. But officials say it posed no danger

The discovery of an illegal medical lab in central California by a code enforcement officer has unleashed an uproar in a rural community and fed anti-Chinese rumors online

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Should Value Investors Go After Pfizer (PFE)?

Pfizer Inc (PFE), currently trading at a discount, is charting a path to enduring expansion via strategic acquisitions and the introduction of novel products. Despite this drive, recent financial results lack significant optimism. Given this scenario, should investors invest in PFE? Let’s look at its financial metrics to gauge its…

The Independent UK

Mexico shutters 23 pharmacies at Caribbean coast resorts after US warned of dangerous pill sales

Mexico has closed 23 pharmacies at Caribbean coast resorts, six months after a research report warned that drug stores in Mexico were offering foreigners pills they passed off as Oxycodone, Percocet, and Adderall

StockNews.com

3 Pharma Stocks Investors Are Chasing for Value

With the advent of advanced medications and the increasing need for personalized treatments, the pharmaceutical industry looks well-poised for long-term growth. Therefore, it could be worth looking into three fundamentally sound pharma stocks, Pfizer (PFE), Sanofi (SNY), and GSK plc (GSK), that are offering significant value. Read more….

The Hindu

WHO medical product alert: one batch of Indian-made combination syrup found contaminated in Iraq

WHO warns of substandard COLD OUT syrup containing unacceptable amounts of diethylene glycol and ethylene glycol. The product may have been distributed to other countries and can be fatal if consumed. Increased vigilance and testing is recommended, as well as informing WHO if the substandard product is discovered.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Pharma Stock Buys You Don’t Want to Miss

The pharmaceutical industry is growing amid robust demand. Also, given that healthcare stocks are generally thought of as defensive investments, fundamentally strong Johnson & Johnson (JNJ), Novo Nordisk (NVO), and AstraZeneca (AZN) might be profitable buys now. Read on.

The Times of India

Concord Biotech IPO: All you need to know

NEW DELHI: Concord Biotech, backed by Rare Enterprises, has announced the price band for its initial public offering (IPO) at Rs 705-741 per share, aiming to raise Rs 1,550 crore.

Dynamite News

Study suggests how HIV drug formulation help improve treatment results for children worldwide

Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dose, safety, and efficacy of a drug formulation designed to treat children infected with the human immunodeficiency virus (HIV). Read further on Dynamite News:

StockNews.com

3 Biotech Stocks Smart Money Is After

Biotech companies such as Biogen (BIIB), Cidara Therapeutics (CDTX), and Theratechnologies (THTX) with the interest of institutional investors could be worth investing in now. Continue reading….

StockNews.com

Let's Talk About Walgreens Boots Alliance (WBA): Buy, Sell, or Hold?

Walgreens Boots Alliance (WBA) is attempting to raise capital and regain market share. Given this scenario, should investors buy, sell, or hold the stock? Let’s look at its financial metrics to gauge its prospects….

StockNews.com

3 Biotech Stocks With Strong Value in August

The biotech industry is ascending with growing R&D initiatives, an upsurge in personalized medicine, and enhanced drug formulations, coupled with the incorporation of technological advancements. So, it seems wise to invest in discounted biotech stocks Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ), and Alkermes (ALKS) this month. Keep reading….

StockNews.com

Are Pfizer (PFE) and AbbVie (ABBV) Good Value Buys for August?

The pharma industry is poised to witness long-term growth with the introduction of generic medicines and growing demand for personalized and targeted treatments. Hence, fundamentally strong pharma stock AbbVie (ABBV) might be worth buying. However, it might not be the right time to invest in Pfizer (PFE). Keep reading.

1 … 47 48 49 50

People

Jennifer Walker Elrod

21 stories

Kristyn Brandi

12 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Department of Justice

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.